Cassava Sciences Announces Closing Of $50M Registered Direct Offering; Shares Move Higher
Cassava Sciences, Inc. (NASDAQ:SAVA) (the "Company" or "Cassava Sciences"), a clinical-stage biotechnology company focused on Alzheimer's disease, today announced the closing of its previously
Graybug Vision Agrees To Merge With Inflammatory Disease-Focused Biopharma
Graybug Vision Inc (NASDAQ:GRAY) and CalciMedica Inc (CalciMedica) have announced a definitive merger agreement to combine the companies in an all-stock transaction. …
Reported Late Monday, Equinox Gold Announces At-The-Market Offering To Sell From Time To Time In Canada And The U.S. Through The The Toronto Stock Exchange ‘TSX’ And The ‘NYSE’ American Such Number Of Common Shares As Would Have An Aggregate Offering P…
Equinox Gold Corp. (TSX:EQX) (NYSE:EQX) ("Equinox Gold" or the "Company") announces that it has entered into an equity distribution agreement dated November 21, 2022 (the "Equity Distribution Agreement") provid
Optinose Announces Pricing Of ~$50M Public Offering Of 26,320,000 Shares Of Common Stock At A Price Of $1.90/Share
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the pricing of an underwritten public offering of 26,320,000 shares of
Surgery Partners, Inc. Announced $275M Proposed Public Offering of Common Stock
Surgery Partners, Inc. (Nasdaq: SGRY) ("Surgery Partners") today announced that it has commenced an underwritten public offering of $275 million of its common stock. All of the shares to be sold in the offering are to be sold by Surgery Partners.